Phibro Animal Health PAHC Ratios & Valuation
| TTM Q3 '26 | TTM Q2 '26 | TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 32.5%+0.6pp | 31.9%+0.7pp | 31.2%+0.3pp | 30.9%-0.8pp | 31.7%-0.2pp | |
| Operating margin | 12%+0.5pp | 11.5%+1.2pp | 10.3%+1.8pp | 8.5%+0.5pp | 8%+0.6pp | |
| Net margin | 6.3%+0.1pp | 6.3%+1.4pp | 4.8%+1.1pp | 3.7%+1.1pp | 2.7%+0.9pp | |
| Returns | ||||||
| Return on equity | 30.3%-1.5pp | 31.8%+8.0pp | 23.8%+6.0pp | 17.8%+5.9pp | 11.9%+4.4pp | |
| Return on invested capital | 46.7%-1.6pp | 48.3%+6.0pp | 42.3%+12.7pp | 29.6%+3.6pp | 26%+6.4pp | |
| Efficiency | ||||||
| Asset turnover | 1.1×0.0× | 1.1×-0.1× | 1.2×+0.1× | 1.1×+0.1× | 1×+0.1× | |
| Liquidity | ||||||
| Current ratio | 3.2×+0.1× | 3.1×0.0× | 3.1×+0.3× | 2.8×-0.1× | 2.9×-0.3× | |
| Leverage | ||||||
| Debt-to-equity | 0.1×0.0× | 0.1×0.0× | 0.1×-0.1× | 0.2×+0.1× | 0.1×0.0× | |
| Net debt / EBITDA | -0.1×0.0× | -0.1×+0.1× | -0.2×-0.2× | -0.1×+0.2× | -0.3×+0.1× | |
| Per Share | ||||||
| Book value per share | $8.82+8.7% | $8.12+6.4% | $7.62+8.6% | $7.02+7.5% | $6.53+7.8% | |
| Valuation | ||||||
| Market capitalization | $1.27B+31.4% | $1.51B-7.7% | $1.64B+63.3% | $1B+16.1% | $865.16M+1.7% | |
| Price / earnings | 13.4×-17.1× | 16.4×-7.7× | 24.2×+3.4× | 20.8×-6.4× | 27.2×-16.8× | |
| Price / sales | 0.9×0.0× | 1×-0.1× | 1.2×+0.4× | 0.8×0.0× | 0.7×0.0× | |
| Price / book | 3.5×-0.1× | 4.6×-0.7× | 5.3×+1.7× | 3.5×+0.3× | 3.3×-0.2× | |
| EV / EBITDA | 5.4×-1.4× | 6.8×-1.5× | 8.2×+1.9× | 6.4×+0.3× | 6×-0.7× | |
| Dividend yield | 1.5%-0.5pp | 1.3%+0.1pp | 1.2%-0.8pp | 1.9%-0.3pp | 2.2%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Phibro Animal Health's profit margins?
- Phibro Animal Health (PAHC) runs a 32.5% gross margin and a 12.0% operating margin, with a 6.3% net margin.
- Where do Phibro Animal Health's ratios come from?
- Every ratio is computed from Phibro Animal Health's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
